Australia Mammography Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Australia Mammography Market is segmented into Product Type (Digital Systems, Analog Systems, Breast Tomosynthesis, and Other Product Types), End Users (Hospitals, Specialty Clinics, and Diagnostic Centers). The market provides the value (in USD million) for the above-mentioned segments.

Australia Mammography Market Size

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
View Global Report
CAGR
Study Period 2019 - 2029
Base Year For Estimation 2023
Market Size (2024) USD 69.28 Million
Market Size (2029) USD 107.93 Million
CAGR (2024 - 2029) 9.27 %
Market Concentration Medium

Major Players

Australia Mammography Market

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Australia Mammography Market Analysis

The Australia Mammography Market size is estimated at USD 69.28 million in 2024, and is expected to reach USD 107.93 million by 2029, growing at a CAGR of 9.27% during the forecast period (2024-2029).

COVID-19 has affected the market studied in Australia significantly. As per the data published in December 2020 by the Australian Institute of Health and Welfare (AIHW), during the first wave of coronavirus infection, screening procedures were postponed in the country. Because of the suspension of breast screening services from March 2020, the cancer screening tests plummeted in the country. However, post lifting the nationwide lockdown in late April and early May 2020, breast screening procedures were recommenced with precautionary measures and longer appointments. On the other hand, the restarting of services was majorly impacted by several jurisdictional infection control guidelines and social distancing requirements. This practice further delayed the rescheduling of appointments for mammograms in women. Considering the urgency of cancer screening tests, the Australian government significantly undertook measures for resuming the procedures to pre-pandemic levels. The alarming decline in the number of breast screenings from January to June forced the healthcare authorities To consider mammograms as important as other healthcare practices. Thus, several breast screening services remained open during the second wave of the pandemic across Victoria. As a result, the breast screening procedures saw an upsurge from July 2020, which may impact the market growth in coming years.

The major factors affecting the growth of the market include the rising incidence of breast cancer, huge R&D in breast cancer therapies, and advances in breast imaging modalities. In August 2021, the National Breast Cancer Foundation (NBCF) and the University of Sydney announced that they would co-invest AUD 5 million in the first 10-Year Chair in Breast Cancer Prevention organized by NBCF. The major focus of the investment would be planning to implement a large-scale breast screening trial using 3D mammography. There is a surge in informative programs and initiatives undertaken by numerous organizations within the country to promote breast cancer awareness among Australian women, and collaborative efforts by the government and non-profit organizations to reduce the breast cancer burden on society. For instance, every October, the 'Not In My Family' mass media campaign is launched by BreastScreen NSW (New South Wales, Australia). The major focus of the campaign is to increase breast screening participation rates in New South Wales (NSW), Australia. Breast cancer management strategies in the country involve contributions from a wide range of government, non-governmental organizations (NGOs), and private institutions.

Therefore, with the above-mentioned factors, the mammography market in Australia is expected to witness strong growth over the forecast period.

Australia Mammography Market Trends

This section covers the major market trends shaping the Australia Mammography Market according to our research experts:

Diagnostic Centers are Expected to Witness Steady Growth Over the Forecast Period

The factors leading to the growth of this segment include the high burden of breast cancer cases and high investments in the country's healthcare sector. Australia also has a highly developed healthcare system that allows patients to avail themselves of the latest technologies. Additionally, awareness programs are also expected to boost the market's growth.

Many developments are taking place in Australia, including launches and approvals, partnerships, collaborations, mergers, and acquisitions in the mammography market. Many new investments are also taking place. For instance, in June 2021, the United Kingdom-based Kheiron Medical Technologies announced that it had received Therapeutic Goods Administration (TGA) clearance from the Australian Government Department of Health and MedSafe WAND Notification from the New Zealand Ministry of Health for its Mia (Mammography Intelligent Assessment) solution. The technology is being launched under a partnership with AI Advance. The Mia solution has been designed to support breast radiologists to help them decide whether or not to recall women for further testing based on their mammography screening. Solutions such as these are likely to be in high demand from diagnostic centers that process many mammograms, leading to market growth.

Additionally, the government funding is also contributing to the growth of the segment studied. For instance, in May 2021, the government of Australia announced that the Australian government is investing USD 353.9 million over the next four years as part of the 2021-22 budget to support women's health, including funding for cervical and breast cancer, endometriosis, and reproductive health.

Hence, owing to the above-mentioned factors, the segment is expected to witness steady growth over the forecast period.

Cancer Data

Australia Mammography Industry Overview

The Australian mammography market is moderately consolidated, owing to the presence of a few major players in the market. The major market players are focusing on technological advancements and reducing the side effects of the procedures. Some of the major players in the market are Analogic Corporation, Canon Medical Systems Corporation, Fujifilm Corporation, GE Healthcare, Hologic Inc., Koninklijke Philips NV, and Siemens Healthineers.

Australia Mammography Market Leaders

  1. Siemens AG

  2. Planmed OY

  3. Fujifilm Holdings Corporation

  4. Hologic Inc.

  5. GE Healthcare

*Disclaimer: Major Players sorted in no particular order

Picture3.png
Need More Details on Market Players and Competitors?
Download PDF

Australia Mammography Market News

  • In July 2021, breast cancer screening and diagnostic company BCAL diagnostics were listed on the Australian securities exchange following an initial public offering that raised USD 10 million from investors.
  • In June 2021, Keiron's ai breast screening solution MIA received regulatory clearance in Australia. With patented AI technology developed on more than 3 million breast images, MIA (mammography intelligent assessment) is designed to support breast radiologists in deciding whether or not to recall women for further testing based on their mammography screening.

Australia Mammography Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Burden of Breast Cancer

      2. 4.2.2 Technological Advancements in the Field of Breast Imaging

    3. 4.3 Market Restraints

      1. 4.3.1 Risk of Adverse Effects from Radiation Exposure

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product Type

      1. 5.1.1 Digital Systems

      2. 5.1.2 Analog Systems

      3. 5.1.3 Breast Tomosynthesis

      4. 5.1.4 Other Product Types

    2. 5.2 By End User

      1. 5.2.1 Hospitals

      2. 5.2.2 Specialty Clinics

      3. 5.2.3 Diagnostic Centers

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Canon Medical Systems Corporation

      2. 6.1.2 Fujifilm Holdings Corporation

      3. 6.1.3 GE Healthcare

      4. 6.1.4 Koninklijke Philips NV

      5. 6.1.5 Siemens Healthineers

      6. 6.1.6 Carestream Health Inc.

      7. 6.1.7 Volpara Health Limited

      8. 6.1.8 Hologic Inc.

      9. 6.1.9 Planmed Oy

      10. 6.1.10 Sonologic

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Australia Mammography Industry Segmentation

As per the scope of the report, mammography refers to a standard diagnostic and screening technique that is used to screen breast tissues to check the presence of a malignant tumor. The process involves the usage of low-energy X-rays for the early detection of breast cancer. Australia Mammography Market is segmented by Product Type (Digital Systems, Analog Systems, Breast Tomosynthesis, and Other Product Types), End Users (Hospitals, Specialty Clinics, and Diagnostic Centers). The report offers the value (in USD million) for the above segments.

By Product Type
Digital Systems
Analog Systems
Breast Tomosynthesis
Other Product Types
By End User
Hospitals
Specialty Clinics
Diagnostic Centers
Need A Different Region Or Segment?
Customize Now

Australia Mammography Market Research FAQs

The Australia Mammography Market size is expected to reach USD 69.28 million in 2024 and grow at a CAGR of 9.27% to reach USD 107.93 million by 2029.

In 2024, the Australia Mammography Market size is expected to reach USD 69.28 million.

Siemens AG, Planmed OY, Fujifilm Holdings Corporation, Hologic Inc. and GE Healthcare are the major companies operating in the Australia Mammography Market.

In 2023, the Australia Mammography Market size was estimated at USD 63.40 million. The report covers the Australia Mammography Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Australia Mammography Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Australia Mammography Industry Report

Statistics for the 2024 Australia Mammography market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Australia Mammography analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Australia Mammography Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)